Bibliography
- Bang HO , DyerbergJ, NielsenA: Plasma lipid and lipoprotein pattern in Greenlandic west-coast Eskimos.Lancet, 297(7710), 1143–1146 (1971).
- Daviglus ML , StamlerJ, OrenciaAJet al..: Fish consumption and the 30-year risk of fatal myocardial infarction. N. Engl. J. Med., 336(15), 1046–1053 (1997).
- Albert CM , HennekensCH, O’DonnellCJet al..: Fish consumption and risk of sudden cardiac death. JAMA, 279(1), 23–28 (1998).
- Albert CM , CamposH, StampferMJet al..: Blood levels of long-chain n-3 fatty acids and the risk of sudden death. N. Engl. J. Med., 346(15), 1113–1118 (2002).
- Siscovick DS , RaghunathanTE, KingIet al..: Dietary intake and cell membrane levels of long-chain n-3 polyunsaturated fatty acids and the risk of primary cardiac arrest. JAMA, 274(17), 1363–1367 (1995).
- Oomen C , FeskensE, RasanenLet al..: Fish consumption and coronary heart disease mortality in Finland, Italy, and The Netherlands. Am. J. Epidemiol., 151(10), 999–1006 (2000).
- Salonen JT , SeppanenK, NyyssonenKet al..: Intake of mercury from fish, lipid peroxidation, and the risk of myocardial infarction and coronary, cardiovascular, and any death in Eastern Finnish men. Circulation, 91(3), 645–655 (1995).
- Kromhout D , BloembergB, FeskensE, HertogM, MenottiA, BlackburnH: Alcohol, fish, fibre and antioxidant vitamins intake do not explain population differences in coronary heart disease mortality.Int. J. Epidemiol., 25(4), 753–759 (1996).
- Roche HM , GibneyMJ: Effect of long-chain n-3 polyunsaturated fatty acids on fasting and postprandial triacylglycerol metabolism.Am. J. Clin. Nutr., 71(1), S232–S237 (2000).
- Morris M , SacksF, RosnerB: Does fish oil lower blood pressure? A meta-analysis of controlled trials.Circulation, 88(2), 523–533 (1993).
- Kristensen S , IversenA, SchmidtE: n-3 polyunsaturated fatty acids and coronary thrombosis.Lipids, 36, S79–S82 (2001).
- Thies F , GarryJM, YaqoobPet al..: Association of n-3 polyunsaturated fatty acids with stability of atherosclerotic plaques: a randomized controlled trial. Lancet, 361, 477–485 (2003).
- McLennan PL , BridleTM, Abeywardena MY, Charnock JS: Comparative efficacy of n-3 and n-6 polyunsaturated fatty acids in modulating ventricular fibrillation threshold in marmoset monkeys. Am. J. Clin. Nutr., 58(5), 666–669 (1993).
- Billman GE , KangJX, LeafA: Prevention of sudden cardiac death by dietary pure omega-3 polyunsaturated fatty acids in dogs.Circulation, 99(18), 2452–2457 (1999).
- Xiao YF , KangJX, MorganJP, LeafA: Blocking effects of polyunsaturated fatty acids on Na+ channels of neonatal rate ventricular myocytes.Physiology, 92, 11000–11004 (1995).
- Honore E , BarhaninJ, AttaliB, LesageF, LazdunskiM: External blockade of the major cardiac delayed-rectifier K+ channel (Kv1.5) by polyunsaturated fatty acids.Pharmacology1937–1944 (1994).
- Hazama H , NakajimaT, AsanoMet al..: Omega-3 polyunsaturated fatty acids – modulation of voltage-dependent L-type Ca2+ current in guinea-pig tracheal smooth muscle cells. Eur. J. Pharmacol., 355, 257–266 (1998).
- Danthi S , EnyeartJ, EnyeartJ: Modulation of native T-type calcium channels by omega-3 fatty acids.Biochem. Biophys. Res. Commun., 327(2), 485–493 (2005).
- Burr ML , FehilyAM, GilbertJFet al..: Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: diet and reinfarction trial (DART) randomized, double-blind, placebo-controlled trial of fish oil and mustard oil in patients with suspected acute myocardial infarction: the Indian experiment of infarct survival. Lancet, 2(8666), 757–761 (1989).
- de Lorgeril M , RenaudS, MamelleNet al..: Mediterranean alpha-linolenic acid-rich diet in secondary prevention of coronary heart disease. Lancet, 343(8911), 1454–1459 (1994).
- Singh RB , NiazMA, SharmaJP, KumarR, RastogiV, MoshiriM: Randomized, double-blind, placebo-controlled trial of fish oil and mustard oil in patients with suspected acute myocardial infarction: the Indian experiment of infarct survival – 4.Cardiovasc. Drugs Ther., 11(3), 485–491 (1997).
- Marchioli R , BarziF, BombaEet al..: Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction: time-course analysis of the results of the Gruppo Italiano per lo Studio della Sopravvivenza nell’Infarto Miocardico (GISSI)-Prevenzione. Circulation, 105(16), 1897–1903 (2002).
- Burr ML , Ashfield-WattPA, DunstanFDet al..: Lack of benefit of dietary advice to men with angina: results of a controlled trial. Eur. J. Clin. Nutr., 57(2), 193–200 (2003).
- Raitt MH , ConnorWE, MorrisCet al..: Fish oil supplementation and risk of ventricular tachycardia and ventricular fibrillation in patients with implantable defibrillators: a randomized controlled trial. JAMA, 293(23), 2884–2891 (2005).
- Leaf A , AlbertCM, JosephsonMet al..: Prevention of fatal arrhythmias in high-risk subjects by fish oil n-3 fatty acid intake. Circulation, 112(18), 2762–2768 (2005).
- Brouwer IA , ZockPL, WeverEFDet al..: Rationale and design of a randomised controlled clinical trial on supplemental intake of n-3 fatty acids and incidence of cardiac arrhythmia: SOFA. Eur. J. Clin. Nutr., 57(10), 1323–1330 (2003).
- Epstein AE , HallstromAP, RogersWJet al..: Mortality following ventricular arrhythmia suppression by encainide, flecainide, and moricizine after myocardial infarction. The original design concept of the Cardiac Arrhythmia Suppression Trial (CAST). JAMA, 270(20), 2451–2455 (1993).
- Chimienti M , CullenMT, CasadeiG, Investigators TFaPISF: Safely of long-term flecainide and propafenone in the management of patients with symptomatic paroxysmal atrial fibrillation: report from the Flecainide and Propafenone Italian Study Investigators. Am. J. Cardiol., 77(3), 60A–75A (1996).
- Kris-Etherton PM , HarrisWS, AppelLJ, for the Nutrition Committee: Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation, 106(21), 2747–2757 (2002).
- FDA Announces Qualified Health Claims for Omega-3 Fatty Acids. FDA News Release, September 8, 2004; P04–89.
- Waldo AL , CammAJ, deRuyterHet al..: Effect of d-sotalol on mortality in patients with left ventricular dysfunction after recent and remote myocardial infarction. Lancet, 348, 7–12 (1996).
- Bardy GH , LeeKL, MarkDBet al..: Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N. Engl. J. Med., 352(3), 225–237 (2005).
- Camm AJ , PrattCM, SchwartzPJet al..: Mortality in patients after a recent myocardial infarction: a randomized, placebo-controlled trial of azimilide using heart rate variability for risk stratification. Circulation, 109(8), 990–996 (2004).
- Kober L , BlochT, MollerMet al..: Effect of dofetilide in patients with recent myocardial infarction and left-ventricular dysfunction: a randomised trial. Lancet, 356, 2052–2058 (2000).